In 2023, John Evans earned $1.13M in total compensation at Beam Therapeutics, including $685.00K salary and $431.55K bonus. Most recently sold 180,000 shares in Jun 2024. Currently holds stock worth $30.60M. Has donated $325.08K in stock to charitable causes. 4+ years at the helm of Beam Therapeutics.
Compensation History
Annual executive compensation data for John Evans, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$1.13M
Salary
$685.00K
Bonus
$431.55K
Other
$17.68K
Salary
$685.00KBoard Justification
The compensation philosophy is centered on pay for performance, aligning executive compensation with the achievement of corporate goals and stockholder value.
Bonus
$431.55KBoard Justification
Based on the achievement of corporate performance goals, resulting in a bonus of 105% of the target amount.
Other Compensation
$17.68KBoard Justification
Includes sabbatical payments, commuting benefits, 401(k) matching contributions, and a cell phone allowance.
Restricted Stock
Board Justification
No stock was vested in 2023 as the focus is on cash compensation and performance-based bonuses.
Performance Metrics
Performance metrics for 2023 included clinical, research and development, manufacturing, organizational, and financial goals.
John Evans
CEO of Beam Therapeutics
Field of Expertise
Healthcare & Life Sciences - Biotechnology
Sector of Economy
Healthcare
CEO of Beam Therapeutics for
4 years 11 months (Jan 2021 - Present)
Previous Experience
CEO of Beam Therapeutics Inc.
Holdings
Track John Evans's stock holdings and portfolio value over time.
Total Stock Sold
$32.09M
$32.09M
676,017 BEAM shares
What if they kept their stock?
If John Evans didn't sell their stock, today they would have:
Extra BEAM676,017 shares worth $18.31M.
This is -42.94% and $13.78M less than what they got when they sold the stock.
Charitable Transactions
12,000 shares
BEAM
Recent Charitable Transactions
12,000 shares
BEAM
Jan 31, 2022
Charity
Insider Trading
John Evans's recent stock transactions, purchases, and sales filed with the SEC.
$4.41M
BEAM at $24.50/share
Jun 27, 2024
Sale
$581.62K
BEAM at $32.13/share
Apr 1, 2024
Sale
77,500 shares
BEAM
Mar 28, 2024
Received
$2.03M
BEAM at $33.86/share
Mar 28, 2024
Sale
$1.52M
BEAM at $25.33/share
Jan 31, 2024
Sale
$346.14K
BEAM at $29.70/share
Apr 3, 2023
Sale
56,250 shares
BEAM
Jan 31, 2023
Received
225 shares
BEAM
Jan 31, 2023
Small Acquisition
$2.32M
BEAM at $46.48/share
Oct 31, 2022
Sale
$3.33M
BEAM at $66.55/share
Jul 28, 2022
Sale
Rivals
Compare John Evans with competitor CEOs and industry peers.